Epilepsy in children with Down syndrome: not so benign as generally accepted

Area of Science:

• Pediatric Neurology
• Clinical Epilepsy Research
• Down Syndrome Studies

Background:

• Down syndrome (DS) is a common genetic disorder associated with intellectual disability and a high prevalence of neurological issues, particularly seizures.
• Epileptic spasms (ES) are the most frequent seizure type observed in children with DS, posing significant treatment challenges.
• Conventional anti-epileptic drugs often demonstrate limited efficacy in managing ES in the general epilepsy population, necessitating exploration of alternative therapeutic strategies.

Purpose of the Study:

• To summarize the clinical experience and treatment outcomes of epilepsy management in children with Down syndrome.
• To evaluate the effectiveness of various treatment regimens, including vigabatrin and steroids, for controlling seizures, specifically epileptic spasms, in this population.
• To compare the observed treatment outcomes with existing literature on epilepsy in Down syndrome.

Main Methods:

• Retrospective review of 12 children with Down syndrome treated for seizures at Antwerp University Hospital.
• Detailed analysis of seizure types, treatment regimens employed (including vigabatrin and steroids), and patient outcomes.
• Focus on patients presenting with epileptic spasms (ES), which were present in eight of the twelve cases.

Main Results:

• The study observed a generally poor outcome in managing epilepsy among children with Down syndrome, contrasting with some previous reports.
• Eight out of twelve children presented with epileptic spasms (ES), highlighting the prevalence of this seizure type.
• The efficacy of steroid treatment for ES was notably low, with a success rate of only 8.3%, despite its recognized role globally.

Conclusions:

• Epilepsy in children with Down syndrome presents a significant therapeutic challenge, often yielding poor treatment outcomes.
• Established treatments like steroids demonstrate limited effectiveness for epileptic spasms in this specific pediatric population.
• Further research into novel and optimized treatment strategies is crucial for improving seizure control and quality of life for children with Down syndrome and epilepsy.